ISRG Stock Price Today (October 2026) — Intuitive Surgical, Inc. Analysis & Key Metrics 2026-10-07
Intuitive Surgical, Inc. (ISRG) is trading at $414.52, up 2.41% today (as of October 2026). The stock continues to show sustained strength above key moving averages, attracting attention from investors looking for Healthcare growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $476.34 (14.9% upside).
- Volatility is low (24.38% annualized), implying relatively contained price movements for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: solid revenue growth (18.50% YoY) alongside competitive pressures in the Medical Instruments & Supplies space.
ISRG Stock Analysis: Key Metrics & Valuation (October 2026)
Concise, actionable data for investors
Intuitive Surgical, Inc. - Historical Price & Volume
- Price
- Volume
- Latest price
Market Cap
Enterprise Value: $143.30B
P/E Ratio
Forward P/E: 31.22
Revenue Growth
Year over Year
Analyst Target
+14.9% upside potential
Key Investor Questions About ISRG
What investors need to know before buying
Based on current market data, ISRG presents a neutral technical setup with mixed signals fundamentals.
- Technicals say: Neutral (RSI 65.55)
- Fundamentals say: Mixed signals (nuanced financial profile)
ISRG's growth trajectory depends on its ability to expand within the Medical Instruments & Supplies sector while managing margin pressures.
- Future growth will depend on performance in core Medical Instruments & Supplies operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for ISRG investors include debt exposure and competitive dynamics in the Medical Instruments & Supplies industry.
- $0.00 in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Medical Instruments & Supplies.
52-Week Trading Range
Over the past year, ISRG stock traded between $328.57 and $603.88 and currently trades in the middle of that range. Big swings are less likely unless a major catalyst emerges.
Volatility & Risk Profile
With 24.38% annualized volatility and β=0.93, the stock exhibits moderate correlation to market moves—making ISRG suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
High institutional ownership with low short interest suggests steadier hands and low immediate risk.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines and coverage
Can This Number Push ISRG Stock Higher?
Intuitive Surgical (ISRG) shares fell 10.4% in the past year, while the S&P 500 returned 16.5%. Much of the market has focused on moderating U.S. procedure growth. The more telling number is 144 trade-ins in fiscal Q2 2026, up from 83 a year earlier. Most came from customers moving to the new da Vinci 5 robot. Those trade-ins matter most if upgrades continue and each surgery also earns more. Is that number a blip, or are customers still trading up.
Buy 3 AI-Powered Medical Stocks to Strengthen Your Portfolio in Q4
AI adoption is reshaping medical devices, with ISRG, TEM and TMO leveraging AI to advance precision medicine and drug development.
Intuitive Surgical Stock Has Plunged 29% This Year. Is the Market Overreacting?
Wall Street thinks that this robotic surgical systems leader's sell-off is overdone.
Intuitive Surgical vs. Stryker: Which MedTech Stock Is the Better Buy Now?
ISRG's rapid procedure growth, expanding robotics ecosystem and recurring revenues highlight its growth path amid MedTech shifts.
Why Intuitive Surgical (ISRG) Is Up 6.5% After New da Vinci SP Transvaginal Approval – And What's Next
Earlier this month, Intuitive Surgical received CE mark approval for using its da Vinci SP single-port robotic system in transvaginal gynecologic procedures, adding to its existing approvals for a range of endoscopic and natural-orifice surgeries across Europe. This world's-first indication for the SP platform deepens Intuitive’s position in minimally invasive, scarless surgery by broadening its clinically supported use in complex anatomical spaces. We’ll now examine how this expanded...
Abbott Laboratories vs. Intuitive Surgical: Recent Quarterly Revenue Trends Reveal a Classic Investing Truth
Abbott leads in absolute revenue, but Intuitive Surgical's growth rate tells a different story over the past eight quarters.
Q2 Earnings Roundup: Intuitive Surgical (NASDAQ:ISRG) And The Rest Of The Surgical Equipment & Consumables - Specialty Segment
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the surgical equipment & consumables - specialty stocks, including Intuitive Surgical (NASDAQ:ISRG) and its peers.
Ambulatory Surgery Centers Are Becoming ISRG's New Growth Engine
Intuitive Surgical is expanding robotic surgery in ASCs with lower-cost XiR systems, opening access to new customers and outpatient procedures.
How Far Could ISRG Stock Bounce From Here?
Intuitive Surgical (ISRG) stock could climb 23.9% to the April high it last fell back from, and you would risk about 5% to find out. That looks like a surgical-robot leader on sale, but the price history disagrees. Over the last two years, none of its visits to this price range turned into a 20% gain before a 5% drop.
Can Intuitive Surgical Make Up For A Lower Price Per Surgery?
Intuitive Surgical (ISRG) has lost about 12% over the past year, while the S&P 500 returned about 17%. Most of the debate has been about the U.S. procedure growth slowing. The number that should worry a holder more is the money the company collects on the instruments used in each operation. Intuitive plans to lower it.
Explore More Analysis for ISRG
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.
Earnings snapshot
Next report Oct 20, 2026 (after the close)
Frequently Asked Questions
Common investor questions about Intuitive Surgical, Inc.
Intuitive Surgical, Inc. (ISRG) is currently trading at $414.52. The RSI (14-day) is at 65.5, indicating neutral territory. Wall Street analysts have a consensus "none" recommendation. The mean analyst price target of $476.34 implies 14.9% upside from current levels. Volatility is moderate at 24.4% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for Intuitive Surgical, Inc. (ISRG): The trailing P/E ratio is 43.34, which is above the market average, indicating investors are pricing in higher growth expectations. The forward P/E is 31.22, lower than the trailing P/E, suggesting analysts expect earnings improvement. The PEG ratio is 1.80, near 1.0, suggesting roughly fair value relative to growth. Price-to-Book is 7.36. Price-to-Sales is 12.27. Valuation should be compared to Medical Instruments & Supplies industry peers for context, as different sectors trade at different multiples.
Based on 29 analysts covering ISRG, the consensus price target is $476.34. This represents a 14.9% upside from the current price of $414.52. The range spans from a low target of $324.00 to a high target of $685.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "none". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Intuitive Surgical, Inc. (ISRG) does not currently pay a regular dividend. The company may be reinvesting profits into growth initiatives, or may not yet be profitable enough to distribute earnings to shareholders.
Key risks for Intuitive Surgical, Inc. (ISRG) investors include: 1. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 2. Medical Instruments & Supplies sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is Intuitive Surgical, Inc.'s (ISRG) current debt and financial health profile: Total debt stands at $0.00. The current ratio is 4.96, indicating strong short-term liquidity. The quick ratio is 3.64. The company holds $5.22B in cash and equivalents. Free cash flow is positive at $2.62B, providing a cushion for debt servicing and shareholder returns.